Trial · NCT00955487
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Combined Endpoint of Bronchopulmonary Dysplasia (BPD) or Mortality | Week 36 or earlier, if participants are discharged from the hospital | Number of participants that developed bronchopulmonary dysplasia and/or that died |
| Primary | Combined Endpoint of Bronchopulmonary Dysplasia (BPD) or Mortality Stratified by Birth Weight | Randomization to discharge | Number of participants that developed bronchopulmonary dysplasia and/or that died, stratified by birth weight (grams) |
| Secondary | Severity of Bronchopulmonary Dysplasia (BPD) | 36 weeks corrected gestational age | Assessment of the severity of BPD as defined by the oxygen reduction test |
| Secondary | Need for Mechanical Ventilation | Anytime after randomization up to 36 weeks corrected gestational age | Number of participants who required endotracheal intubation and mechanical ventilation |
| Secondary | Total Ventilation Days | After randomization up until hospital discharge | Of those participants who required mechanical ventilation, the total number of days receiving ventilation |
| Secondary | Necrotizing Enterocolitis (NEC) | After randomization through hospital discharge | Number of participants diagnosed with necrotizing enterocolitis |
| Secondary | Symptomatic PDA Requiring Medical Treatment | From randomization until discharge | Number of participants with a symptomatic PDA that required medical treatment |
| Secondary | Symptomatic PDA Requiring Surgical Ligation | Randomization through discharge | Number of participants with symptomatic PDA that required surgical ligation |
| Secondary | Threshold Retinopathy of Prematurity (ROP) | Randomization to discharge | Threshold ROP defined as requiring interventional therapy |
| Secondary | Severe Intracranial Hemorrhage | Randomization to discharge | Number of participants that developed severe intracranial hemorrhage (grade 3-4) |
| Secondary | Sepsis | Randomization to discharge | Number of participants that developed sepsis |
| Other | Days in Hospital | From birth to hospital discharge | Length of stay of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00955487/registered